The verified answer
As of Oct 2026, DEPLOY verifies DSM-Firmenich: 1 model. 1 source back the record.
Overview
DSM-Firmenich (SIX: DSFIR) is a Swiss-Dutch health and materials Science company. Makes strategic investments in biotechnology, food processing automation, and AI-powered materials development. Formed by 2023 merger of Royal DSM and Firmenich.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Key facts
Focus
Stage
Scale
Products
Data & sources
Web sources
1
1 source backing this record.View all →
Models (1)
View all models →Partnerships
Every company DSM-Firmenich has built with, alongside the ones only announced in a press release.
Most-frequent partners
- 1Microsoft1× joint351 total
Most recent
DSM-Firmenich on the deployment map
View the global mapDSM-Firmenich has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for DSM-Firmenich on the DEPLOY record yet. Track DSM-Firmenich to know the moment the first one is verified.
Relationships
Current leadership (1)
- Dimitri de Vreeze CEOreported, not verified
Safety record
No incidents on record for DSM-Firmenich.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
DSM-Firmenich in third-party press
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- mature
- Counterparty risk class
- low
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Partnerships
1 total · 1 operating
Every company DSM-Firmenich has built with, alongside the ones only announced in a press release.
Most recent
Most-frequent partners
- 1Microsoft1× joint351 total
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 8, 2026
Added to the verified registry
Sources (1)
Common questions
What is DSM-Firmenich?
What does DSM-Firmenich make?
Is DSM-Firmenich publicly traded?
Who is the CEO of DSM-Firmenich?
How can I invest in DSM-Firmenich?
Where is DSM-Firmenich headquartered?
Who owns DSM-Firmenich?
Where does DSM-Firmenich operate robots?
Is DSM-Firmenich a top robotics company?
Is DSM-Firmenich safe?
Methodology: Verified · 1 source (no primary) · last reviewed 2026-08-21
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-21
Sources by quality tier
- 1
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for DSM-Firmenich.In the press
Recent coverage mentioning DSM-Firmenich from third-party publications. Automatically surfaced; not part of the verified registry record.
Richard Ridinger Set to Guide dsm-firmenich’s Next Chapter as Proposed Chair
(IN BRIEF) dsm-firmenich has announced that Thomas Leysen, Chair of the Board of Directors, has decided to retire from the Board once shareholders elect a successor, following the…
dsm-firmenich takes Protopia yeast protein to industrial scale, targets fishmeal and whey
Protopia could generate a novel revenue stream for Indian ethanol producers who are sitting on significant underutilized capacity. The post dsm-firmenich takes Protopia yeast…
Osborne Clarke advises dsm-firmenich Ventures on its investment in Nous - Osborne Clarke
<a…
DSM Firmenich (ENXTAM:DSFIR) Stock Valuation After Landmark FDA Approval For Parsol Shield - simplywall.st
<a…
Dividend Investors: Don't Be Too Quick To Buy DSM-Firmenich AG (AMS:DSFIR) For Its Upcoming Dividend - simplywall.st
<a…
dsm-firmenich Q1 2026 trading update - NTB Kommunikasjon
<a…
From fragrance labs to food tech: dsm-firmenich's CEO on why Singapore is the innovation catalyst for Asia's wellness future - Singapore Economic Development Board (EDB)
<a…
Assessing DSM-Firmenich (ENXTAM:DSFIR) After A 37% One-Year Share Price Slide - simplywall.st
<a…
AgriFood Signals: Dicamba reinstated, Bayer gets Stryax green light, SP Ventures closes $50m - AgFunderNews
<a…
SLAS Highlights: AI Labs, Small-Molecule SPR, Protein Interaction Assays, and Paper Labware - genengnews.com
<a…
dsm-firmenich to Divest Animal Nutrition & Health Business to CVC in €2.2 Billion Deal - iGrow News
<a…
DSM‑Firmenich’s €2.2bn ANH exit underscores ‘barbell’ reality in animal health investment - agnavigator.com
<a…
Machine-readable surfaces
- Markdown mirror: /companies/dsm-firmenich.md
- RSS feed: /companies/dsm-firmenich/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/0d682259-23ce-4ec1-bc56-8e7495968b51
- Revision history: /companies/dsm-firmenich/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Heat Index
Serious52/100
A composite of competitive footprint, funding, press velocity, active partnerships, and supply-chain edges. Different from the Intelligence score below (which is per-form-factor productization). Non-robotics companies cap at 25.
Reality vs attention
DSM-Firmenich draws attention at the 61st percentile but verifies reality at the insufficient-data level among other robots.
6-month trend
Analysis
Limited public funding data for capital position assessment.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Oct 4, 2026